healthcarenewsblogs

  Global peripheral nerve stimulators market expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 750.36 million in 2018 and is projected to grow at a CAGR of 7.7% over the forecast period. Peripheral Nerve Stimulators is expected to grow at a significant growth rate. The major factors influencing the growth of the market include; rising economic growth, increasing geriatric devices, increasing growth in technological advancement in the field of medical devices, rising neurological disorders, rising incidence of chronic health problems, and others. Key Players Some of the major players operating in the global peripheral nerve stimulators market are B. Braun Melsungen AG, NeuroSigma, Inc, NeuroMetrix, Inc., Avanos Pain Management, Enteromedics, ElectroCore, Inc., Vygon SA, Boston Scientific Corporation, Medline Industries, Inc SPR Therapeutics LLC, Stimwave LLC., SUNMED INC., and others. Request Free Sample Copy a

  The global nuclear imaging devices market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 2490 million in 2018 and is projected to register a CAGR of 5.2% over the forecast period.However, the high cost of the nuclear imaging device, shorter half-life of radiopharmaceuticals can hamper market growth over the forecast period. The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.Various other factors such as the advancements in radiotracers, acceptance of nuclear imaging devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on diagnostic imaging centers are also expected to

  The increasing prevalence of cardiovascular disorders and growing older population are the key factors driving the automatic pill dispenser market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.Various other factors such as the advancements in automatic pill dispenser, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on home care centers are also expected to propel the growth of the market. The Global Automatic Pill Dispenser Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 1,700 million in 2018 and is projected to register a CAGR of 7.3% over the forecast period.However, the high cost of the system can hamper market growth over the forecast period. Request Free Sample Copy at: https://www.marketresearch

  An artificial heart is a pump which is designed to replace heart ventricles to restore normal functioning. Unavailability of donors, allograft coronary diseases, and various other limitations are increasingly favoring artificial hearts. They are used as a bridge to provide permanent mechanical cardiac support, and its success is being evidenced by number of artificial hearts working successfully across the globe. Market Research Future (MRFR) has recently published an in-depth report on the global artificial heart market and has cited rising incidence of cardiac disorders among the primary drivers of the growth of the artificial heart market. The report is a compilation of various other pertinent trend and factors that can impact the growth of the market in the coming years. As per MRFR's analysis, the artificial heart market is anticipated to register a CAGR of 15.1% 2019-2024. Technological advancements, aggressive R&D activities, clinical trials, and massive support fro

  Increasing demand for testing new drugs and chemicals and vigorous growth in the pharmaceutical and biopharmaceutical sectors are expected to drive the market growth. However, the bioanalysis and drug metabolism and pharmacokinetics (DMPK) studies segment is projected to exhibit the highest CAGR of 8.96% from 2019 to 2024. New technological developments by various companies to provide better services to pharmaceutical companies is driving the growth of the segment. The Global Preclinical CRO Market is estimated to be valued at USD 5,234.7 Million by 2024 and is expected to register a CAGR of 8.14% during the forecast period. Americas accounted for the largest market share of 40.7% in 2018, and the regional market is projected to register a CAGR of 7.49% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Indian market is projected to exhibit the highest growth rate of 9.44% during the forecast period of 2019 to 2024. Market Players Market Res

  Numerous factors such as a high level of research activities in live cell encapsulation technologies and the rising awareness programs in various countries are anticipated to fuel the growth of the market. Moreover, the increasing investments by various public and private organizations have created a lucrative option for many companies to invest in providing new encapsulation techniques, leading to the overall growth of the market. Furthermore, the inclination towards novel drug delivery systems for disease management fuels the growth of the market during the forecast period. It is estimated that the Global Live Cell Encapsulation Market is expected to register a CAGR ~ 3.22% during the forecast period of 2018 to 2023, with an estimated market value of USD 249.87 million in 2017.However, the lack of skilled technicians, and ethical and legal issues, and unaffordability of various small-scale companies to enter the market due to high product manufacturing costs are expected to curb

  It is estimated that the Global Ultrasound Gastroscopes Market valued USD 630.2 million in 2017 and is anticipated to register a CAGR of ~ 6.32% during the forecast period of 2018 to 2023. Ultrasound gastroscopes are medical devices used as a minimally invasive technique to diagnose and treat several diseases of the gastrointestinal tract such as gastrointestinal cancers, pancreatic conditions, and others. The growing prevalence of gastric cancers such as upper and lower GI cancers, higher accuracy, and specificity of endoscopy ultrasound techniques, growing geriatric population, and technological advancements are some of the major factors boosting the growth of global ultrasound gastroscopes market. According to the data by the World Health Organization, there were about 1.03 million cases of stomach cancer globally in the year 2018. However, the lack of skilled professionals and high cost associated with this device are considered to hamper the growth of the market over the fore

  Vacuum system maintains the pressure inside a chamber under the value of the atmospheric pressure. A medical vacuum system provides a safe, adequate flow of vacuum, and the required pressure to be used in the healthcare facilities such as operating theaters (OTs), intensive care centers, and emergency and respirology/general medicine units. These systems create a suction system to eliminate unnecessary fluids or gases from hospital or laboratory working areas. Factors facilitating the market growth are worldwide growing geriatric population, increasing number of surgical and diagnostic imaging procedures, technological developments in vacuum equipment, and the presence of regulatory frameworks mandating the use of vacuum systems in the healthcare settings coupled with rising adoption of medical vacuum systems. The global medical vacuum systems market held a market value of USD 1,030.5 million in 2017 and is projected to grow at a CAGR of 7.1% over the forecast period. For instance

  The deep penetration of healthcare IT globally has created a conducive environment for the growth of the market. Other factors fueling the growth of the market include government initiatives to transform the healthcare sector and reduce the burden of chronic diseases. On the contrary, market growth might be hindered by the inflated cost of EHR-EMRs. The global EHR-EMR market , as per the latest report published by Market Research Future (MRFR), is a rapidly expanding market and is poised to reach USD 42,427.27 Mn at a CAGR of 5.82% by the end of the forecast period of 2018-2027. EHR-EMRs help to significantly improve quality and coordination of medical services due to which are being increasingly adopted across the globe. Competitive Landscape Koninklijke Philips NV, GE Healthcare, Athenahealth, Inc., Meddbase (Medical Management Systems Ltd), Cerner Corporation, eClinicalWorks, Agastha, Inc., AdvancedMD Inc., Allscripts Healthcare Solutions, Medical Information Technology, Inc.

  Business intelligence is a set of processes, architectures, and technologies used for the collection, integration, analysis, and presentation of business information. Healthcare data analytics provides healthcare companies and hospitals to prepare, analyze & visualize big and disparate data. Factors characterizing the market growth are the worldwide surge in the number of patient registries, increasing adoption of big data in healthcare, the presence of government initiatives to increase electronic health record (EHR) adoption, and growing need to curb healthcare costs. On the contrary, the lack of skilled professionals in the Asia-Pacific and African regions along with the complexity of systems is anticipated to hinder the market growth over the forecast period. The global healthcare business intelligence (BI) market held a market value of USD 3,650.1 million in 2017 and is projected to grow at a CAGR of 15.5% over the forecast period. Novel trends in the healthcare business